Clare Stirzaker

Clare Stirzaker is a distinguished professional with a solid background in Epigenetics, currently serving as the Group Leader for Epigenetic Deregulation in Cancer at the Garvan Institute of Medical Research.

Throughout her career, Clare has made significant contributions to the field of DNA methylation and epigenetic deregulation in cancer, pioneering new technologies and methodologies in epigenetic research.

With a Ph.D. in Molecular Biology from Macquarie University and a Bachelor of Science (Hons) in Biochemistry and Molecular Biology from the University of Cape Town, Clare boasts a strong educational foundation.

Her research interests center around mapping epigenetic deregulation in cancer, particularly in breast and prostate cancer, and her group's discoveries have paved the way for the development of biomarkers and potential therapeutic targets.

Clare's expertise lies in understanding the mechanisms underlying aberrant DNA methylation, with a keen focus on Long Range Epigenetic deregulation and regional gene silencing and activation in cancer.

Having held roles as a Senior Research Officer at various prestigious institutions such as the Garvan Institute of Medical Research, University of Sydney, and Kanematsu Laboratories, Clare's professional journey is marked by a commitment to advancing the field of Epigenetics.

As a former Conjoint Senior Lecturer at UNSW and an Associate Professor, Clare has also contributed significantly to academia through her teaching and mentorship.